Principal Investigator: Dr. Leigh Beglinger

Study Description:  CIT-HD is a clinical trial for individuals who are not currently taking anti-depressant medication, who notice mild changes in their thinking abilities, and who are diagnosed with HD.  The trial evaluates citalopram (or Celexa) effects on HD symptoms.  Citalopram is currently approved by the FDA for the treatment of depression.  This is a double blind placebo-controlledstudy, meaning not everyone will take citalopram during the study.  Participation lasts for 17 weeks and compensation is provided.  The University of Iowa is the only HD Center of Excellence conducting this study.